Group items matching

in title, tags, annotations or url

The National Multiple Sclerosis Society believes in a world free of MS and is dedicated to ensuring that people affected by MS can live their best lives. To that end, the organization is currently accepting applications for its Harry Weaver Neuroscience Scholar Award, which is named for Harry Weaver, PhD, known worldwide for his contribution to neuroscience and multiple sclerosis research and the society's director of research from 1966-1977. Over the course of his tenure and career, Weaver encouraged young investigators to enter and pursue MS research and broaden understanding of basic and clinical aspects of multiple sclerosis. Through the program, five-year grants in support of salary and research will be awarded to highly-qualified candidates who have concluded their research training and begun their academic careers as an independent investigator in an area related to multiple sclerosis. Up to 75 percent of annual salary support may be requested, not to exceed $75,000 in year one, as well as up to $30,000 for research-associated direct costs, with incremental increases possible in each of the remaining four years.

The Janett Rosenberg Trubatch Career Development Award, supported by the Trubatch Family, recognizes originality and creativity in research and promotes success during academic transitions prior to tenure.

The Peter and Patricia Gruber International Research Award, supported by The Gruber Foundation, recognizes two young neuroscientists for outstanding research and educational pursuit in an international setting.

The Young Investigator Award, supported by AstraZeneca, recognizes the outstanding achievements and contributions by a young neuroscientist who has recently received his/her advanced professional degree.

The Next Generation Award recognizes SfN chapter members who have made outstanding contributions to public communication, outreach, and education about neuroscience.

The Grass Foundation and the American Neurological Association (ANA) are now accepting nominations for The Grass Foundation - ANA Award in Neuroscience.  This Award was established in 2007 to honor outstanding young investigators doing research in basic or clinical neuroscience.  The Grass Foundation www.grassfoundation.org was established in 1955 by Albert and Ellen Grass to advance research and education in neuroscience, with a special focus on investigators early in their careers. 

The purpose of the NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award is to support a defined pathway across career stages for outstanding graduate students who are from diverse backgrounds underrepresented in neuroscience research. This two-phase award will facilitate completion of the doctoral dissertation and transition of talented graduate students to strong neuroscience research postdoctoral positions, and will provide career development opportunities relevant to their long-term career goal of becoming independent neuroscience researchers.

This NIA Research Career Enhancement Award (K18) program invites applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer's Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD or AD-related dementias (ADRD). This award will also allow data scientists to redirect their expertise toward the study of AD and ADRD.

The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. These awards were established to encourage emerging neuroscientists to focus on disorders of learning and memory. Applicants for the McKnight Scholar awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience.

Recipients of the award are inspired individuals with projects that show potential to generate new knowledge relating to causes, cure, or treatment of primary brain tumors/brain cancer. The annual award provides up to $600,000 in funding over a four-year period. Over that time, recipients also receive additional support from the foundation through its network of scientists in the field and an annual alumni conference.

This award recognizes excellence in research in the history of neurology. Submission evaluation is based primarily on the originality of the work and the clarity with which ideas are expressed.

The Prize, established in 2004, is an unrestricted cash award of $500,000, a gold medal inscribed with the recipient's name, and a citation describing the achievement for which the recipient is being honored. It is awarded each year to a person or persons chosen by a distinguished advisory board of neuroscience experts from nominations that are received from around the world.

The Scolnick Prize is designed to recognize outstanding advances in the field of neuroscience. The prize, which is endowed through a gift from Merck to the institute, consists of a $100,000 award, plus an inscribed gift. In addition, the recipient will present a public lecture at the McGovern Institute in spring 2015. A gala dinner for the recipient and invited guests follows the prize lecture. Candidates for the award must be nominated by individuals who are affiliated with universities, hospitals, medicals schools, or research institutes, and who possess a background in neuroscience. Self-nomination is not permitted

The FY15/16 VRP Technology/Therapeutic Development Award (TTDA) is a mission-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including detection, diagnosis, treatment, or quality of life, in at least one of the FY15/16 VRP TTDA Capability Gaps. Products in development should be responsive to the health care needs of military Service members, Veterans, and other individuals living with visual dysfunction. 

The intent of the NETPR Program Career Progression Award is to support independent, early-career investigators who have innovative, high-impact ideas or new technologies applicable to PD research and/or patient care. This award provides an opportunity to obtain the funding and experience necessary for productive career progression at the forefront of research specifically on non-motor aspects of PD. Preliminary data to support the feasibility and rationale of the proposed work are required. Any preliminary data provided should be from the laboratory of the PI or collaborators. 

The PH/TBIRP Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award is being offered for the first time in FY18. The overarching goal of this effort is to improve our understanding of the impact of mild TBI (mTBI)/concussion on Service members and Veterans. The FY18 PH/TBIRP LIMBIC Award will support a Consortium conducting a single large longitudinal study and associated sub-studies within the scope of the Program Announcement/Funding Opportunity. The knowledge gained through the proposed studies will be used to inform TBI pathways of care and illuminate specific target areas to improve acute TBI care and subsequent support systems for chronic care following mTBI.

The NIH Directors Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative research towards the ultimate goal of enhancing human health. Individuals from diverse backgrounds are encouraged to apply. Applications in all topics, including, but not limited to, the behavioral, social, biomedical, applied, and formal sciences, relevant to the broad mission of NIH are welcome and may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

The Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) award will support students at institutions without formal NIH-funded institutional predoctoral dual-degree training programs. The purpose of this FOA is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g., DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individuals' potential to develop into a productive, independent physician/clinician-scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

The purpose of the NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award is to support a defined pathway across career stages for outstanding graduate students who are from backgrounds that are nationally underrepresented in neuroscience research. This two-phase award will facilitate completion of the doctoral dissertation and transition of talented graduate students to strong neuroscience research postdoctoral positions, and will provide career development opportunities relevant to their long-term career goal of becoming independent neuroscience researchers.

The PRARP New Investigator Research Award (NIRA) mechanism is being offered for the first time in FY17. The intent of the FY17 PRARP NIRA is to support early-career investigators interested in novel research efforts or new technologies within TBI and AD/ADRD in support of the PRARP's mission (see Section II.A, Program Description). The FY17 PRARP NIRA is open to Principal Investigators (PIs) within 3 years of their first independent faculty position, from any field or discipline. As part of the application, the PI should demonstrate that the study team has experience in both TBI and AD/ADRD research. Preliminary data, while not required, are encouraged. Preliminary data may come from the PI's published work, pilot data, or from peer-reviewed literature. Note that PIs will be required to verify their eligibility for this award. The anticipated direct costs budgeted for the entire period of performance for an FY17 PRARP NIRA will not exceed $225,000. The maximum period of performance is 3 years.